Showing 4461-4470 of 5808 results for "".
- Aspiring Physician with Psoriasis Among AbbVie Scholarship Recipientshttps://practicaldermatology.com/news/aspiring-dermatologist-with-psoriasis-among-abbvie-scholarship-recipients/2461201/AbbVie has awarded 45 scholarships as part of its 2022-2023 AbbVie Immunology Scholarship program. The program, which provides financial support to students living with chronic, immune-mediated diseases pursuing higher education in the United States, received more than 1,000 applic
- Ophthalmologist Ashley Brissette, MD Launches Eye Area Skincare Linehttps://practicaldermatology.com/news/ophthalmologist-ashley-brissette-md-launches-eye-area-skincare-line/2461193/Daily Practice, the new eye care line by ophthalmologist Ashley Brissette, MD, has launched with a hero product—Eye Revive. Having worked as an ophthalmologist for six years, New York City-based Dr. Brissette says she recognized a growing trend of
- Indoor Tanning Ban Could Slash Melanoma Deathshttps://practicaldermatology.com/news/indoor-tanning-ban-could-slash-melanoma-deaths/2461190/An indoor tanning ban in England would reduce melanoma deaths, according to a study by University of Manchester researchers. By tracking the projected impact on the 618,000 18-year-olds living in England in 2019, the research team showed that a ban on indoor tanning would resu
- Handheld Device May Painlessly Identify Skin Cancershttps://practicaldermatology.com/news/handheld-device-may-painlessly-identify-skin-cancers/2461188/Researchers at Stevens Institute of Technology are developing a low-cost handheld device that could cut the rate of unnecessary biopsies in half and give dermatologists and other frontline physicians easy access to laboratory-grade cancer diagnostics. “We aren’t trying
- CeraVe Shares Real Stories of Four Nurses with the Return of Heroes Behind the Maskshttps://practicaldermatology.com/news/cerave-shares-real-stories-of-four-nurses-with-the-return-heroes-behind-the-masks/2461186/In honor of National Nurses Week, CeraVe reinforces its commitment to the nursing community with the premiere of
- Stratpharma Inc. USA Names Michael Flowers President of North American Commercial Operationshttps://practicaldermatology.com/news/stratpharma-inc-usa-names-michael-flowers-president-of-north-american-commercial-operations/2461185/Michael Flowers is now President of North America Commercial Operations for Stratpharma Inc. in the United States. Mr. Flowers joins Stratpharma from WSI, where he served as Chief Commercial Officer. Stratpharma Inc. USA is the US subsidi
- Castle Biosciences Supports Patient-Focused Initiatives for Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/castle-biosciences-supports-of-patient-focused-initiatives-for-skin-cancer-awareness-month/2461182/Castle Biosciences, Inc. will continue its ongoing collaboration with the Melanoma Research Foundation (MRF) and The Skin Cancer Foundation to support skin cancer research, education and advocacy, highlighting events during May, in recognition of Skin Cancer Awareness Month. “We a
- Healthy-appearing Lupus Skin Predisposed to Flares, Rasheshttps://practicaldermatology.com/news/healthy-appearing-lupus-skin-predisposed-to-flares-rashes/2461181/Normal-appearing skin of lupus patients contains the same inflammatory signals that are detected when the skin develops a rash – sometimes at even higher levels, according to a study in Science Translational Medicine. “This really starts to piece the puzzle together
- Ready for Prime Time? Ampel’s Blood Tests May Predict Drug Options for Inflammatory Skin Diseasehttps://practicaldermatology.com/news/ready-for-prime-time-ampels-blood-tests-may-predict-drug-options-for-inflammatory-skin-disease/2461179/Ampel BioSolutions machine learning approach can characterize disease activity from gene expression data obtained from patient skin biopsy and may revolutionize the way doctors treat inflammatory skin diseases, according to research published in Science Advances. The lab test
- FDA Approves Sol-Gel Technologies' and Galderma's Epsolay for Rosaceahttps://practicaldermatology.com/news/fda-approves-sol-gel-technologies-and-galdermas-epsolay-for-rosacea/2461170/The FDA has approved Sol-Gel Technologies' Epsolay, a proprietary cream formulation of benzoyl peroxide, 5%, for the treatment of inflammatory lesions of rosacea in adults. The benzoyl peroxide in Epsolay is encapsulated within silica-based patented microcapsules. The silica-based s